A CD147-targeted small-molecule inhibitor potentiates gemcitabine efficacy by triggering ferroptosis in pancreatic ductal adenocarcinoma.
Cell reports. Medicine • 2025
Li J, Ma C, Cao P, et al.
PubMed entryPhenolics
CAS 643-56-1
Catalog SYL-006
Procurement Options
Pack sizing, price visibility, and availability for direct checkout or inquiry.
1 mg
$30.00
5 mg
$55.00
25 mg
$225.00
100 mg
$750.00
Freebase Dracorhodin; this product is not dracorhodin perchlorate.
Freebase Dracorhodin analytical standard for Dragon’s blood resin profiling and pigment analysis. In stock for research use.
Dracorhodin is a red phenolic pigment reported in Dragon’s blood resin and used as a marker compound in resin analysis. This product is the neutral/freebase form, not dracorhodin perchlorate; the two forms have different CAS numbers, formulas, and molecular weights. It is suited to HPLC or LC-MS identity confirmation, resin-content assays, pigment characterization, and research evaluating antimicrobial or antioxidant activity.
COA and SDS are available on request. Submit an inquiry for lot-specific analytical data.
Store at −20°C, protected from light and moisture. Allow the sealed vial to reach room temperature before opening, and minimize light exposure during weighing and solution preparation.
Published Research
Selected peer-reviewed references indexed in PubMed.
PubMed entries
48
Selected papers are shown below.
A CD147-targeted small-molecule inhibitor potentiates gemcitabine efficacy by triggering ferroptosis in pancreatic ductal adenocarcinoma.
Cell reports. Medicine • 2025
Li J, Ma C, Cao P, et al.
PubMed entryHypoglycemic effects of dracorhodin and dragon blood crude extract from Daemonorops draco.
Botanical studies • 2024
Ching YH, Lin FM, Chen HC, et al.
PubMed entryDracorhodin perochlorate sensitizes colorectal cancer to ferroptosis by activating HMOX1 and inhibiting the SLC7A11/GPX4 axis.
International immunopharmacology • 2025
Niu X, Wang M, Wang M, et al.
PubMed entryIn vivo pro-angiogenic effects of dracorhodin perchlorate in zebrafish embryos: A novel bioactivity evaluation platform for commercial dragon blood samples.
Journal of food and drug analysis • 2019
Krishnaraj P, Chang Y, Ho TJ, et al.
PubMed entry